Pacific Biosciences of California PACB Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrentAndNoncurrent.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's accrued expenses?
- Pacific Biosciences of California (PACB) reported accrued expenses of $13.4M in Q1 2026.
- How has Pacific Biosciences of California's accrued expenses changed year-over-year?
- Pacific Biosciences of California's accrued expenses increased by 140.6% year-over-year, from $5.57M to $13.4M.
- What is the long-term trend for Pacific Biosciences of California's accrued expenses?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's accrued expenses has grown at a -33.2% compound annual growth rate (CAGR), from $15.26M to $2.03M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.